Significant Ownership of Ansbert Gadicke
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ansbert Gadicke focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Boston, MA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Ansbert Gadicke with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Ansbert Gadicke
Significant Ownership of Ansbert Gadicke
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTSQ | AKTIS ONCOLOGY, INC. | Common Stock | 19% | $102,601 | 10,260,064 | ANSBERT GADICKE | 12 Jan 2026 | ||
| ITOS | ITEOS THERAPEUTICS, INC. | Common Stock | 4.7% | $13,259,371 | 1,803,996 | ANSBERT GADICKE | 13 May 2025 | ||
| RPTX | REPARE THERAPEUTICS INC. | Common Shares | 4.6% | $2,135,366 | -$228,990 | 1,941,242 | -9.7% | ANSBERT GADICKE | 31 Jan 2025 |
| HOWL | WEREWOLF THERAPEUTICS, INC. | Common Stock | 3.8% | $1,680,514 | -$719,307 | 1,826,646 | -30% | ANSBERT GADICKE | 08 May 2026 |
Schedules 13D/G Reported by Ansbert Gadicke:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.